Gabapentin Capsule
Product Images NDC 80425-0163
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Gabapentin (NDC 80425-0163). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Advanced Rx Pharmacy Of Tennessee, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Fig 2
This appears to be a chart or graph related to a study on different dosages of Gabapentin for pain management. The chart shows the mean pain score at baseline and over several weeks for four groups: a placebo group, a group taking 1800mg/day of Gabapentin, a group taking 2400mg/day of Gabapentin, and a group undergoing a dose titration period. Beyond that, the text provides no additional information.*
Fig 3
The text represents a chart or table showing the proportion of responders in controlled PHN studies at endpoint. The chart shows percentage scores ranging from 10% to 100% in increments of 10%. The table provides additional data for each study, including study number, percentage of responders (ranging from 12% to 29%), and the names of different treatments (GBP 3600, PBO, GEBP 1800, and GBP 2400). There is a reference to "#p<00l < 0,001," indicating statistical significance, but it is not clear what this refers to without further context.*
Fig 4
Formula
Gabapentin 400mg Tab Qty 90 Ndc 80425 0163
Structure
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.